Insider · CIK 0001410781

JOHNSON JOHN

Reports to the SEC for 15 companies · ALACHUA, FL

sec.gov

Transactions

Companies

Filings

CIK

0001410781

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,392 sh	—	—	4,392
2026-06-19	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+14.2K sh	—	—	0
2026-06-19	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.2K sh	—	—	14,150
2026-06-04	XERSXeris Biopharma Holdings, Inc.S Sale	Director	SSale	−15K sh	$6.09	−$91.4K	683,083
2026-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+24.2K sh	—	—	707,276
2026-06-04	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	$6.15	+$203K	32,996
2026-05-21	VSTMVerastem, Inc.A Award	Director	AAward	+36K sh	—	—	52,666
2026-05-07	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	$7.04	+$77.8K	11,050
2026-05-07	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2026-05-07	AXGNAxogen, Inc.S Sale	Director	SSale	−11.1K sh	$43.26	−$478K	0
2025-12-19	XERSXeris Biopharma Holdings, Inc.S Sale	Director	SSale	−135K sh	$7.22	−$977K	698,083
2025-12-09	AXGNAxogen, Inc.S Sale	Director	SSale	−13.1K sh	$29.98	−$394K	0
2025-12-09	AXGNAxogen, Inc.S Sale	Director	SSale	−8,545 sh	$29.98	−$256K	13,141
2025-12-09	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,545 sh	$6.30	+$53.8K	21,686
2025-12-09	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−8,545 sh	—	—	0
2025-12-08	AXGNAxogen, Inc.S Sale	Director	SSale	−11.8K sh	$31.26	−$369K	13,141
2025-12-08	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	8,545
2025-12-08	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	$6.30	+$74.9K	25,032
2025-12-08	AXGNAxogen, Inc.S Sale	Director	SSale	−11.9K sh	$31.22	−$371K	13,141
2025-08-13	XERSXeris Biopharma Holdings, Inc.S Sale	Director	SSale	−108K sh	$7.32	−$786K	833,483
2025-06-19	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+14.2K sh	—	—	14,150
2025-06-09	AXGNAxogen, Inc.S Sale	Director	SSale	−4,073 sh	$10.61	−$43.2K	24,943
2025-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50K sh	—	—	940,983
2025-05-22	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2025-05-22	VSTMVerastem, Inc.A Award	Director	AAward	+8,333 sh	—	—	16,666
2024-12-19	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+1M sh	—	—	1,000,000
2024-12-19	APLTApplied Therapeutics, Inc.A Award	Director, Executive Chairman	AAward	+500K sh	—	—	500,000
2024-09-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	0
2024-09-01	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	—	—	29,016
2024-06-18	VSTMVerastem, Inc.A Award	Director	AAward	+8,333 sh	—	—	8,333
2024-06-18	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-06-06	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)A Award	Director	AAward	+18.2K sh	—	—	18,248
2024-06-06	AXGNAxogen, Inc.A Award	Director	AAward	+10.7K sh	—	—	17,112
2024-06-05	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50K sh	—	—	890,983
2024-03-18	XERSXeris Biopharma Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+216K sh	$1.99	+$429K	751,412
2024-03-18	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−216K sh	—	—	0
2024-03-15	XERSXeris Biopharma Holdings, Inc.J Other	Director	JOther	+89.6K sh	—	—	840,983
2024-03-11	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,549 sh	—	—	8,549
2024-03-11	VSTMVerastem, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,083 sh	—	—	0
2024-03-11	VSTMVerastem, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,300 sh	—	—	0
2024-03-11	VSTMVerastem, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,083 sh	—	—	0
2024-03-11	VSTMVerastem, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,083 sh	—	—	0
2023-09-01	AXGNAxogen, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+20.4K sh	—	—	20,436
2023-09-01	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+11.9K sh	—	—	11,904
2023-06-07	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+42.5K sh	—	—	535,812
2023-06-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,459 sh	—	—	0
2023-06-01	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,459 sh	—	—	6,459
2023-05-15	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Director	AAward	+62.5K sh	—	—	62,500
2022-06-22	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Director	AAward	+62.5K sh	—	—	62,500
2022-06-08	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Jun 264
JOHNSON JOHN0001410781-26-000008
SEC(opens sec.gov)
Jun 234
JOHNSON JOHN0001410781-26-000006
SEC(opens sec.gov)
Jun 54
JOHNSON JOHN0001410781-26-000004
SEC(opens sec.gov)
May 264
JOHNSON JOHN0001104659-26-066412
SEC(opens sec.gov)
May 84
JOHNSON JOHN0001410781-26-000002
SEC(opens sec.gov)
Dec 194
JOHNSON JOHN0001410781-25-000006
SEC(opens sec.gov)
Dec 104
JOHNSON JOHN0001410781-25-000004
SEC(opens sec.gov)
Aug 154
JOHNSON JOHN0001867096-25-000141
SEC(opens sec.gov)

Companies

Address

C/O AXOGEN, INC. 13631 PROGRESS BLVD. SUITE 400

ALACHUA, FL, 32615